KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Current Taxes: 2018-2024

  • Adaptive Biotechnologies' Current Taxes rose 198.31% to $176,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $176,000, marking a year-over-year increase of 198.31%. This contributed to the annual value of $176,000 for FY2024, which is 198.31% up from last year.
  • Adaptive Biotechnologies' Current Taxes amounted to $176,000 in Q4 2024, which was up 198.31% from $59,000 recorded in Q4 2023.
  • Adaptive Biotechnologies' 5-year Current Taxes high stood at $1.8 million for Q4 2020, and its period low was $59,000 during Q4 2023.
  • In the last 3 years, Adaptive Biotechnologies' Current Taxes had a median value of $176,000 in 2024 and averaged $143,000.
  • Its Current Taxes has fluctuated over the past 5 years, first plummeted by 77.87% in 2021, then skyrocketed by 198.31% in 2024.
  • Over the past 5 years, Adaptive Biotechnologies' Current Taxes (Quarterly) stood at $1.8 million in 2020, then crashed by 77.87% to $391,000 in 2021, then tumbled by 50.38% to $194,000 in 2022, then tumbled by 69.59% to $59,000 in 2023, then spiked by 198.31% to $176,000 in 2024.
  • Its last three reported values are $176,000 in Q4 2024, $59,000 for Q4 2023, and $194,000 during Q4 2022.